Trials / Completed
CompletedNCT02627989
An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study intends to investigate patient satisfaction of treatment with Ointment (W/O emulsion) formulations of Potency Class II topical corticosteroids (TCs) for atopic dermatitis (AD) patients in Japan. Objectives include measuring patient satisfaction, treatment adherence, itchiness, and AD severity scores.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diflucortolone valerate (Nerisona) | Potency Class II (classified as Very Strong class in Japan) topical corticosteroids |
| DRUG | Diflucortolone valerate (Texmeten) | Potency Class II (classified as Very Strong class in Japan) topical corticosteroids |
Timeline
- Start date
- 2015-12-10
- Primary completion
- 2016-11-17
- Completion
- 2017-01-17
- First posted
- 2015-12-11
- Last updated
- 2020-04-01
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02627989. Inclusion in this directory is not an endorsement.